Obesity is recognized as a perpetual state of chronic low-grade inflammation, through systemic and paracrine increase in levels of cytokines, chemokines and adipokines.[6] Besides its direct impact on inflammation, obesity can also modify pharmacokinetics of anti-TNF and other biologic agents. The gene discussed is TNF; the disease is obesity disorder.